0000714256 2026-07-29 2026-07-29 true 0000714256 8-K/A 2026-07-29 SANARA MEDTECH INC. TX 001-39678 59-2219994 1200 Summit Avenue Suite 414 Fort Worth TX 76102 (817) 529-2300 true false false false Common Stock, $0.001 Par Value SMTI NASDAQ false This Amendment No. 1 (this “Amendment”) to the Current Report on Form 8-K originally filed by Sanara MedTech Inc. (the “Company”) with the Securities and Exchange Commission on July 29, 2026 (the “Original Report”) is being filed to amend and restate the Original Report. The only change to the Original Report is to correct an error in Item 1.01 in the Original Report that inadvertently reported (i) the amount of the termination fee payable by the Company in certain circumstances as $22,540,785.00 as opposed to the correct termination fee of $9,660,336.00 and (ii) the amount of the termination fee payable by MiMedx Group, Inc. in certain circumstances as $9,660,336.00 as opposed to the correct termination fee of $22,540,785.00.